Literature DB >> 79609

Antigen-specific T cell-mediated suppression. II. In vitro induction by I-J-coded L-glutamic acid50-L-tyrosine50 (GT)-specific T cell suppressor factor (GT-T8F) of suppressor T cells (T82) bearing distinct I-J determinants.

R N Germain, J Theze, C Waltenbaugh, M E Dorf, B Benacerraf.   

Abstract

The induction of new suppressor T cells (Ts2) by suppressive extracts (TsF) from L-glutamic acid50L-tyrosine50 (GT) nonresponder mice was examined. Incubation of normal spleen cells with allogeneic GT-TsF for 2 days in vitro led to the generation of Ts2 cells able to suppress subsequent responses to the immunogen GT-methylated bovine serum albumin (GT-MBSA) in vivo. This induction occurred efficiently when TsF donor and target cells differed at all of H-2, including the I-J subregion. B10.BR (H-2k) GT-TsF, adsorbed on, then acid eluted from GT-Sepharose and anti-I-Jk [B10.A (3R) anti-B10.A (5R)]-Sepharose in a sequential fashion could induce BALB/c (H-2d) spleen cells to become Ts2 only if nanogram quantities of GT were added to the purified GT-TsF. This indicates a requirement for a molecule or molecular complex possessing both I-J determinants and antigen (GT)-binding specificity, together with GT itself, for Ts2 induction. The induced Ts2 are I-J+, since their function can be eliminated by treatment with anti-I-Jk plus C. These I-J determinants are coded for by the precursor of the Ts2 and do not represent passively adsorbed, I-J coded TsF, since anti-Ijk antiserum [(3R X DBA/2)F1 anti-5R] which cannot recognize the BALB/c (I-Jd) TsF used for induction still eliminates the activity of induced A/J (I-Jk) Ts2. These data provide further evidence for and information about the minimum of two T cells involved in antigen-specific suppressor T cell systems.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79609

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Characterization of efferent T suppressor cells induced by Paracoccidioides brasiliensis-specific afferent T suppressor cells.

Authors:  B E Jimenez-Finkel; J W Murphy
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor.

Authors:  P L Fidel; J W Murphy
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 3.  Antigen-specific T-cell factors.

Authors:  M J Taussig
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

Review 4.  Epitope-specific and idiotype-specific cellular interactions in a model protein antigen system.

Authors:  E E Sercarz; D W Metzger
Journal:  Springer Semin Immunopathol       Date:  1980-08

5.  Induction of suppressor cells by staphylococcal enterotoxin B: identification of a suppressor cell circuit in the generation of suppressor-effector cells.

Authors:  M Holly; Y S Lin; T J Rogers
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

6.  Immune response gene regulation of the humoral immune response to Porphyromonas gingivalis fimbriae in mice.

Authors:  H Shimauchi; T Ogawa; S Hamada
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

Review 7.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

8.  Differential sensitivity of lymphocyte subsets to corticosteroid treatment.

Authors:  P Rogers; A Matossian-Rogers
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

9.  Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection.

Authors:  W F Green; D G Colley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

10.  Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cells.

Authors:  M H Dietz; M S Sy; B Benacerraf; A Nisonoff; M I Greene; R N Germain
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.